Page 60 - வடமேற்கு பல்கலைக்கழகம் ஃபைன்பெர்க் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வடமேற்கு பல்கலைக்கழகம் ஃபைன்பெர்க் பள்ளி ஆஃப் மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வடமேற்கு பல்கலைக்கழகம் ஃபைன்பெர்க் பள்ளி ஆஃப் மருந்து Today - Breaking & Trending Today

Why Clinical Laboratorians Should Embrace the R Programming Language


Like many other industries, clinical laboratories are becoming more reliant on data analytics. Clinical laboratories generate, process, and store transactional data with high quality and efficiency. These data are required for patient care and quality assurance activities and increasingly are used for operational decisions. To analyze all these data, laboratories often rely on commercial spreadsheets or other specialized software applications. However, these programs can be functionally limited and often are not suitable for more complex statistical analyses and visualizations or for analysis of large or high-dimensional datasets. Importantly, the analysis and visualization workflows in these programs have limited reproducibility and transparency. ....

University Of Pennsylvania , United States , Hadley Wickham , Roberth Lurie , Shannon Haymond , A Perfect Fit For Clinical Laboratory Data , Michael Palmieri Laboratory For Metabolic , R Archive Network , Perelman School Of Medicine , Northwestern University Feinberg School Of Medicine , Community Of Users , What Are Its , Microsoft Excel , Key Attributes , Broad Based Community , Comprehensiver Archive Network , Customr Based , Perfect Fit , Clinical Laboratory , Stack Overflow , Data Science , Northwestern University Feinberg School , Perelman School , Michael Palmieri Laboratory , Advanced Diagnostics , Incorrect Implementation ,

Northwestern University: Sossina Haile and Dimitri Krainc awarded Ver Steeg Fellowship


Share
Northwestern University professors Sossina Haile and Dr. Dimitri Krainc have received the 16th annual Dorothy Ann and Clarence L. Ver Steeg Distinguished Research Fellowship Award.
Haile, of the McCormick School of Engineering, is a fuel cell pioneer whose work focuses on sustainability and social good on a global scale. Krainc, of Northwestern University Feinberg School of Medicine, is an outstanding investigator in the field of neurodegenerative research whose work has paved the way for investigations into novel therapeutics.
Bestowed by the Office of the Provost, the Ver Steeg Fellowship supports scholarship and research by tenured Northwestern faculty whose work enhances the national and international reputation of the University. The honor includes a $40,000 award for each recipient. ....

United States , Dimitri Krainc , Sossina Haile , Kathleen Hagerty , Sossina Hailesossina Haile , Walterp Murphy , Dorothy Ann , American Ceramics Society , Mccormick School Of Engineering , Office Of The Provost , Davee Department Of Neurology , National Science Foundation , Institute For Sustainability , Materials Research Society , Northwestern University Feinberg School Of Medicine , Simpson Querrey Center , California Institute Of Technology , Northwestern University , African Academy Of Sciences , Association Of American Physicians , Steeg Distinguished Research Fellowship , Mccormick School , Northwestern University Feinberg School , Ver Steeg Fellowship , Professors Sossina Haile , Ver Steeg Award ,

Oncolytics Biotech® Announces Clinical and Biomarker Data Demonstrating Clinical Proof-of-Concept for Pelareorep-Checkpoint Inhibitor Combination in Pancreatic Cancer


Share this article
Share this article
SAN DIEGO, Calif. and CALGARY, AB, May 20, 2021 /PRNewswire/ Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced clinical and biomarker data demonstrating clinical proof-of-concept for pelareorep-checkpoint inhibitor combination therapy in pancreatic cancer. The data will be featured in an upcoming electronic poster presentation at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, which is taking place virtually from June 4 – 8, 2021.
The newly announced data are from a phase 2 trial evaluating pelareorep in combination with the PD-1 inhibitor pembrolizumab (KEYTRUDA®) in pancreatic adenocarcinoma patients who progressed after first-line treatment. Findings from the trial indicate that pelareorep and pembrolizumab synergize and show anti-cancer activity in these difficult-to-treat patients, which is mediated through the complementary immunotherapeutic effects of the two agents. ....

United States , Devalingam Mahalingam , Jon Patton , Timothy Mccarthy , Thomas Heineman , Oncolytics Biotech Inc , American Society Of Clinical Oncology , Company Contact , American Cancer Society Inc , Global Head Of Clinical Development , Northwestern University Feinberg School Of Medicine , Oncolytics Biotech , Securities Exchange , Roberth Lurie Comprehensive Cancer Center , Northwestern University , American Cancer Society , Clinical Oncology , Annual Meeting , Principal Investigator , Associate Professor , Northwestern University Feinberg School , Comprehensive Cancer Center , Global Head , Clinical Development , Colorectal Cancer , Pancreatic Cancer ,